|
⚲
|
| Keyboard |
| Butler John P
✚
|
|
|---|---|
| CIK # | 0001591467 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001591467] | |
| 4 | [0001591467] | |
| 5 | [0001591467] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Butler John P | |
| Akebia Therapeutics Inc | |
| Zynerba Pharmaceuticals Inc | |
| Keryx Biopharmaceuticals Inc | |
| Relypsa Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-03-04 | Buy | 69,270 | $1.25 | 86,588 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-02-02 | Sell | 83,689 | $1.39 | 116,328 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-02-02 | Grant | 175,250 | $1.41 | 247,102 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-02-02 | Sell | 114,891 | $1.39 | 159,698 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-02-02 | Sell | 96,065 | $1.39 | 133,530 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-02-02 | Sell | 46,660 | $1.39 | 64,857 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2026-01-30 | Grant | 743,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2026-01-30 | Grant | 1,115,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2025-03-03 | Sell | 46,409 | $1.83 | 84,928 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2025-02-03 | Sell | 46,268 | $2.10 | 97,163 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2025-02-03 | Sell | 97,982 | $2.10 | 205,762 |
|
Akebia Therapeutics Inc AKBA
Performance Stock Units · derivative
|
2025-01-31 | Grant | 350,500 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2025-01-31 | Grant | 701,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2025-01-31 | Grant | 1,051,400 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2024-02-29 | Sell | 46,570 | $1.58 | 73,581 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2024-02-27 | Sell | 37,733 | $1.52 | 57,354 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2024-02-01 | Sell | 46,489 | $1.68 | 78,102 |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2024-01-31 | Grant | 603,500 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2024-01-31 | Grant | 905,200 | $0.00 | |
|
Zynerba Pharmaceuticals Inc ZYNE
Common Stock
|
2023-10-10 | Tender | 32,941 | ||
| showing 20 of 110 most recent transactions | |||||